Description
Product Name:
NACMAC-AB Tablets
Description:
NACMAC-AB Tablets is a fixed-dose combination medication used to manage respiratory conditions associated with mucus overproduction, airway obstruction, and inflammation. It is particularly effective in treating symptoms such as blockage, chest congestion, and irritation in chronic and acute pulmonary disorders.
Composition:
Each film-coated tablet contains:
- Acebrophylline – 100 mg
- N-Acetylcysteine (NAC) – 600 mg
Indications:
NACMAC-AB is indicated in the treatment of:
- Chronic bronchopulmonary diseases (e.g., chronic emphysema)
- Acute bronchopulmonary conditions (e.g., pneumonia, bronchitis, tracheobronchitis)
- Pulmonary complications associated with cystic fibrosis
- Atelectasis caused by mucus obstruction
- Chronic Obstructive Pulmonary Disease (COPD)
- Bronchial asthma
Mechanism of Action:
- Acebrophylline combines the benefits of bronchodilation, mucoregulation, and anti-inflammatory action. It contains theophylline-7-acetate (a bronchodilator) and ambroxol (a mucolytic agent), making it effective in clearing airway passages and reducing inflammation.
- N-Acetylcysteine (NAC) acts as a potent mucolytic agent and antioxidant. It breaks down thick mucus by disrupting the disulfide bonds in mucoproteins via its sulfhydryl groups, thereby reducing mucus viscosity and facilitating easier expectoration.
Dosage & Administration:
To be taken as directed by healthcare professionals.
Storage Instructions:
Store in a dry place at room temperature, not exceeding 30°C. Keep away from direct sunlight and moisture.
Packaging:
NACMAC-AB is available in Alu-Alu strips of 10 tablets.
Reviews
There are no reviews yet.